Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Fanny, Ofek"'
Autor:
Fanny Ofek, Dana Barchel, Nofar Perets, Tomer Ziv-Baran, Ahmad Mahajna, Talia Filipovich-Rimon, Osnat Garach-Jehoshua, Maya Berlin, Matitiahu Berkovitch
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Introduction: In patients treated with direct oral anti activated factor X (anti-FXa) anticoagulants such as apixaban and rivaroxaban, there are several emergency and non-emergency conditions in which anticoagulation activity should be measured. The
Externí odkaz:
https://doaj.org/article/bdf71e7c73564bd8ad25085f578c4a52
Autor:
Maya Berlin, Dana Barchel, Revital Gandelman-Marton, Nurit Brandriss, Ilan Blatt, Tomer Ziv-Baran, Miri Y. Neufeld, Natalie Dinavitser, Elkana Kohn, Dotan Shaniv, Tal De-Haan, Fanny Ofek, Gideon Koren, David Stepensky, Matitiahu Berkovitch
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 10 (2019)
Background: Epilepsy is one of the most common chronic neurological conditions and its treatment during pregnancy is challenging. Levetiracetam (LEV) is an antiepileptic medication frequently used during pregnancy. Only a few small studies have been
Externí odkaz:
https://doaj.org/article/01589cccff8b421c946fc57effe44a1e
Publikováno v:
Clinical Therapeutics. 39:1003-1010
Direct factor Xa inhibitors such as rivaroxaban or apixaban may prolong prothrombin time (PT) and elevate international normalized ratio (INR). However, these tests are not reliable for assessing the anticoagulation effects of these agents. PT assay
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c129bd24505217c5967773b2bf4f3e9
https://doi.org/10.1016/j.clinthera.2017.04.007
https://doi.org/10.1016/j.clinthera.2017.04.007
Autor:
Matitiahu Berkovitch, Maya Berlin, Dana Barchel, Ahmad Mahajna, Fanny Ofek, Tomer Ziv-Baran, Talia Filipovich-Rimon, Osnat Garach-Jehoshua, Nofar Perets
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Frontiers in Pharmacology
Frontiers in Pharmacology
Introduction: In patients treated with direct oral anti activated factor X (anti-FXa) anticoagulants such as apixaban and rivaroxaban, there are several emergency and non-emergency conditions in which anticoagulation activity should be measured. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2da08531298b86fa1eff6749900c323
https://www.frontiersin.org/article/10.3389/fphar.2019.01177/full
https://www.frontiersin.org/article/10.3389/fphar.2019.01177/full
Autor:
Matitiahu Berkovitch, Revital Gandelman-Marton, Miri Y. Neufeld, Ilan Blatt, Tomer Ziv-Baran, Dotan Shaniv, Elkana Kohn, Maya Berlin, Dana Barchel, Gideon Koren, David Stepensky, Nurit Brandriss, Tal De-Haan, Fanny Ofek, Natalie Dinavitser
Publikováno v:
Therapeutic Advances in Chronic Disease
Therapeutic Advances in Chronic Disease, Vol 10 (2019)
Therapeutic Advances in Chronic Disease, Vol 10 (2019)
Background: Epilepsy is one of the most common chronic neurological conditions and its treatment during pregnancy is challenging. Levetiracetam (LEV) is an antiepileptic medication frequently used during pregnancy. Only a few small studies have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::889130ecfec5053769b1995594a4a9a1
https://pubmed.ncbi.nlm.nih.gov/31191874
https://pubmed.ncbi.nlm.nih.gov/31191874
Publikováno v:
Israel Journal of Health Policy Research
Background Intravenous potassium chloride (IV KCl) solutions are widely used in hospitals for treatment of hypokalemia. As ampoules of concentrated KCL must be diluted before use, critical incidents have been associated with its preparation and admin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dceebfe699fcce7a639a48cd5f89c786
http://europepmc.org/articles/PMC5088650
http://europepmc.org/articles/PMC5088650
Autor:
Berlin, Maya, Kronenfeld, Nirit, Dinavitser, Natalie, Brik, Anna, Cohen, Rana, Fanny, Ofek, Wiener, Yifat, Berkovitch, Matitiahu
Publikováno v:
In Reproductive Toxicology September 2019 88:138-138